{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-eu-ctr-ctis-submissions-and-lifecycle-management”
},
“headline”: “SOP for EU CTR/CTIS Submissions and Lifecycle Management”,
“description”: “This SOP describes procedures for managing clinical trial submissions and lifecycle activities under the EU Clinical Trials Regulation (CTR) and the Clinical Trials Information System (CTIS). It covers sponsor and CRO responsibilities, substantial modifications, results submission, and compliance with EMA transparency requirements.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for EU CTR/CTIS Submissions and Lifecycle Management

Purpose

The purpose of this SOP is to outline procedures for submission and lifecycle management of clinical trials under the European Union Clinical Trials Regulation (EU CTR 536/2014) via the Clinical Trials Information System (CTIS). This ensures regulatory compliance, transparency, and harmonized trial management across EU member states.

Scope

This SOP applies to sponsors, CROs, regulatory affairs personnel, and QA staff involved in EU CTR submissions. It covers initial trial application, substantial modifications, ongoing trial updates, results posting, transparency compliance, and inspection readiness under EMA oversight.

Responsibilities

• Sponsor: Ensures timely preparation and submission of CTR applications and lifecycle documents.
• CRO: Supports regulatory submission preparation, translation management, and document upload in CTIS.
• Regulatory Affairs: Reviews and submits CTIS entries, manages communications with NCAs and Ethics Committees.
• QA: Audits submission processes, verifies document integrity, and ensures readiness for EMA inspections.
• Investigator: Provides site-level documentation and ensures consistency with CTR requirements.

Accountability

The Sponsor’s Regulatory Affairs Lead is accountable for all EU CTR/CTIS submissions and lifecycle management activities. CROs share accountability for delegated responsibilities.

Procedure

1. Initial Clinical Trial Application
1.1 Prepare CTA dossier according to EU CTR Annex I.
1.2 Upload documents (protocol, IMPD, IB, informed consent, etc.) in CTIS.
1.3 Record submission in EU CTR Application Log (Annexure-1).

2. Validation and Assessment
2.1 Monitor validation requests from Member States.
2.2 Respond to requests within required timelines (10/12 days).
2.3 Document in Validation Response Log (Annexure-2).

3. Substantial Modifications
3.1 Identify modifications requiring resubmission (e.g., protocol amendments, safety changes).
3.2 Submit through CTIS with justification.
3.3 Record in Modification Log (Annexure-3).

4. Ongoing Trial Updates
4.1 Update recruitment status, investigator sites, and safety reports in CTIS.
4.2 Document in Ongoing Update Log (Annexure-4).

5. Results Posting
5.1 Submit summary results within 12 months of trial completion.
5.2 Pediatric trials must be posted within 6 months.
5.3 Record in Results Submission Log (Annexure-5).

6. Transparency and Public Disclosure
6.1 Ensure consistency with EMA transparency rules.
6.2 Flag documents requiring confidentiality protection.
6.3 Record in Transparency Log (Annexure-6).

7. Archiving and Inspection Readiness
7.1 Maintain inspection-ready CTIS records.
7.2 Archive all CTR/CTIS documents in TMF.
7.3 Document in Archiving Log (Annexure-7).

Abbreviations

• SOP: Standard Operating Procedure
• EU CTR: European Union Clinical Trials Regulation
• CTIS: Clinical Trials Information System
• CTA: Clinical Trial Application
• EMA: European Medicines Agency
• CRO: Contract Research Organization
• QA: Quality Assurance
• TMF: Trial Master File

Documents

1. EU CTR Application Log (Annexure-1)
2. Validation Response Log (Annexure-2)
3. Modification Log (Annexure-3)
4. Ongoing Update Log (Annexure-4)
5. Results Submission Log (Annexure-5)
6. Transparency Log (Annexure-6)
7. Archiving Log (Annexure-7)

References

• EMA – Clinical Trials Information System (CTIS)
• EU Clinical Trials Regulation (EU CTR 536/2014)
• ICH GCP – International Standards

Version: 1.0

Approval Section

Annexures

Annexure-1: EU CTR Application Log

Annexure-2: Validation Response Log

Annexure-3: Modification Log

Annexure-4: Ongoing Update Log

Annexure-5: Results Submission Log

Annexure-6: Transparency Log

Annexure-7: Archiving Log

Revision History

For more SOPs visit: Pharma SOP